Back to trial details

Intake questionnaire

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

Applying to Rheumatic Disease Associates, Ltd. · Willow Grove, Pennsylvania

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 18 and 75 years old?
2. Have you been diagnosed with Lupus Nephritis?
3. Are you able to travel to Willow Grove for study visits?